All In Biotech

Guides

How to find every FDA-approved drug for a condition

Find FDA approved drugs for any condition by searching indications on current FDA labels, grouped by drug class, with the limits of the search explained.

By the All In Biotech editorial team · Published November 18, 2026 · 6 min read

The most reliable way to find every FDA-approved drug for a condition is to search the Indications and Usage section of current FDA drug labels, because that section is where FDA states each approved use. This site's condition search does that for you: type a disease and it lists every brand-name prescription drug and biologic whose current label names it, grouped by FDA pharmacologic class.

It is a word search on labels, so it has limits. This guide explains how it works, how to read the results, and where to double-check.

Why the label is the source of truth

A drug is "FDA-approved for" a condition only if that use appears in its FDA-approved labeling, also called the prescribing information. Section 1 of the label, Indications and Usage, lists every approved use, often with conditions on age, disease stage, prior treatment or biomarkers.

Other sources can mislead. News articles and drug company websites may mention uses still in trials. Clinical guidelines may recommend drugs for uses FDA never reviewed, which is legal off-label prescribing but not an FDA approval. Searching the label text avoids both problems. For a tour of the rest of the label, see how to read an FDA drug label.

How the condition search works

The search runs against FDA's structured product labels, published through openFDA, and checks them against the Drugs@FDA catalog. In detail:

  1. Each condition has a set of phrases. For example, the obesity page searches for "chronic weight management" and "obesity", the wording FDA labels use. High cholesterol searches for "hyperlipidemia", "hypercholesterolemia" and "LDL-C".
  2. Labels are matched on Indications and Usage only. A drug that mentions the condition elsewhere, for example as a side effect or in a warning, is not listed.
  3. Only human prescription drug labels count. Over-the-counter products are excluded.
  4. Brand-name NDAs and BLAs are listed. Each match is linked to its application in Drugs@FDA, so you can open its approval history and current label.
  5. Generic labels are counted. Generic drugs approved through ANDAs are shown as a count of matching generic applications rather than one by one.
  6. Results are grouped. Marketed drugs are grouped by their FDA pharmacologic class (for example, GLP-1 receptor agonists or SGLT2 inhibitors), largest group first. Within the list, marketed drugs come first, then novel drugs, then the most recent first approval.

The site's search bar suggests listed conditions as you type, including common alternative names such as "high blood pressure" for hypertension or "AFib" for atrial fibrillation. If what you type does not match a listed condition, the site searches label indications for the words you typed in the same way.

Reading the results

Each condition page shows the drugs FDA has approved for it according to their current labels, and states the label phrases it matched. A few habits help:

  • Read the indication text, not just the drug name. Open the drug page to see the full approved use. Two drugs listed for breast cancer may be approved for very different patients, such as early versus metastatic disease, or tumors with a specific mutation.
  • Check whether a product is still marketed. As of November 2026, 3,248 of the 5,899 brand-name applications in this site's Drugs@FDA catalog have at least one product still marketed. Discontinued brands may still have a label online.
  • Use the class grouping to see options. For hypertension, dozens of drugs fall into a handful of classes. The grouping makes it easier to see which mechanisms are approved.
  • Note the generic count. A high generic count usually means older, widely available treatments. A condition with few or no generics is often served only by newer brands.

The limits, and how to work around them

A label-text search is fast and transparent, but it is not the same as a clinical review. These are the main ways it can mislead.

Subtypes and broader terms

Labels often name a subtype rather than the general disease. A drug approved for "HER2-positive metastatic breast cancer" will appear under breast cancer, but the listing alone does not tell you which subtype. The reverse also happens: a search for a broad word can match labels for a different condition that shares the word. For example, a phrase like "pancreatic" can match labels that mention pancreatic enzyme insufficiency as well as pancreatic cancer. Read each indication to confirm.

Add-on and restricted use

Many approvals are limited to use with other drugs, or after other drugs have failed. The 2026 approval of Baxfendy (baxdrostat), for instance, is for hypertension in combination with other blood pressure drugs. Such a drug is approved for the condition, but not as a first or only treatment. The indication text says so; the listing does not.

Mentions that are not approvals

The Indications and Usage section sometimes names a condition in a "Limitations of Use" statement, to say a drug should not be used for it. A type 2 diabetes drug's label, for example, may state that it is not for type 1 diabetes. A word search can pick up those mentions, so a drug may appear under a condition it is explicitly not approved for. Always check the indication text on the drug page.

Different wording

If a label uses wording that is not among the condition's phrases, it will not match. Rare diseases with several names, or older labels written in older terms, are most affected. Try searching alternative names in the search bar, and the drug's own page if you know its name.

What is not in the data

  • Most vaccines, blood products and cell and gene therapies are approved by FDA's Center for Biologics Evaluation and Research (CBER). They are not in Drugs@FDA, so they are not linked here even if their label matches.
  • Very new approvals can take time to appear in openFDA's label data. The novel approvals list shows the latest CDER approvals, and the 2026 novel approvals report lists this year's.
  • Off-label uses are not approvals and will not appear.
  • Drugs in development for a condition are in trial registries, not labels. Each condition page links to recruiting trials for the condition, and the trial search covers registered drug trials by area and phase.

Checking a result against official sources

For any drug you plan to cite, confirm the current indication on DailyMed, the National Library of Medicine's label database, or in Drugs@FDA. Labels change when FDA approves new uses or restricts old ones, and the label date on each drug page shows which version was used.

If you want to see when each use was added, the approval history on the drug page lists the original approval and every efficacy supplement. As of November 2026, this site tracks 7,565 approvals since 2000, including efficacy supplements for new uses, populations and doses. The Drugs@FDA guide explains how to read that history directly at FDA.

Example conditions to start from

These condition pages are a good test of how the search behaves across very different diseases:

Whatever you find, treat the list as a starting point for reading labels, not as a treatment recommendation. Decisions about a specific patient belong with a clinician.

Frequently asked questions

How do I find all FDA-approved drugs for a disease?
Search the Indications and Usage sections of current FDA drug labels for the condition's name, which is what this site's condition search does using openFDA label data.
Does the list include generic drugs?
Brand-name NDAs and BLAs are listed by name, while generic (ANDA) labels that name the condition are counted but not listed one by one.
Why might a drug I expect be missing?
The label may use different wording, the drug may be approved by FDA's biologics center outside Drugs@FDA, or the drug may be used off label rather than approved for that condition.
Does an approved drug for a condition mean it is right for every patient?
No. Labels often limit a use to a subtype, a line of therapy or add-on use, and only a clinician can judge whether a drug fits a patient.

For information only, not medical, legal or investment advice. Facts about FDA and CMS programs are current as of the publication date; check the linked official source for changes.

Keep reading